Gene · 1052
Papers3,093
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,093
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arachidonic Acid Added during the Differentiation Phase of 3T3-L1 Cells Exerts Anti-Adipogenic Effect by Reducing the Effects of Pro-Adipogenic Prostaglandins. | Life (Basel) | 2023 | 36836723 | PubTator, text mining | PubMed |
| Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression. | Int J Mol Sci | 2023 | 36835312 | PubTator, text mining | PubMed |
| Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. | Int J Mol Sci | 2023 | 36834633 | PubTator, text mining | PubMed |
| Acquisition of Immune Privilege in GBM Tumors: Role of Prostaglandins and Bile Salts. | Int J Mol Sci | 2023 | 36834607 | PubTator, text mining | PubMed |
| Genetic Factors Implicated in the Investigation of Possible Connections between Alzheimer's Disease and Primary Open Angle Glaucoma. | Genes (Basel) | 2023 | 36833265 | PubTator, text mining | PubMed |
| Role of PI3K-AKT Pathway in Ultraviolet Ray and Hydrogen Peroxide-Induced Oxidative Damage and Its Repair by Grain Ferments. | Foods | 2023 | 36832881 | PubTator, text mining | PubMed |
| A Wrong Fate Decision in Adipose Stem Cells upon Obesity. | Cells | 2023 | 36831329 | PubTator, text mining | PubMed |
| Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective. | Cells | 2023 | 36831310 | PubTator, text mining | PubMed |
| Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers. | Cells | 2023 | 36831248 | PubTator, text mining | PubMed |
| The Role of Pericytes in Regulation of Innate and Adaptive Immunity. | Biomedicines | 2023 | 36831136 | PubTator, text mining | PubMed |
| Massively parallel characterization of psychiatric disorder-associated and cell-type-specific regulatory elements in the developing human cortex. | bioRxiv | 2023 | 36824845 | PubTator, text mining | PubMed |
| BHLHE40/41 regulate macrophage/microglia responses associated with Alzheimer's disease and other disorders of lipid-rich tissues. | bioRxiv | 2023 | 36824752 | PubTator, text mining | PubMed |
| MAPKAPK2-centric transcriptome profiling reveals its major role in governing molecular crosstalk of IGFBP2, MUC4, and PRKAR2B during HNSCC pathogenesis. | Comput Struct Biotechnol J | 2023 | 36817960 | PubTator, text mining | PubMed |
| Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma. | World J Gastroenterol | 2023 | 36816628 | PubTator, text mining | PubMed |
| Exhaustion‑like dysfunction of T and NKT cells in an X‑linked severe combined immunodeficiency patient with maternal engraftment by single‑cell analysis. | Int J Mol Med | 2023 | 36799159 | PubTator, text mining | PubMed |
| Regulon active landscape reveals cell development and functional state changes of human primary osteoblasts in vivo. | Hum Genomics | 2023 | 36793138 | PubTator, text mining | PubMed |
| The biological impacts of CEBPD on urothelial carcinoma development and progression. | Front Oncol | 2023 | 36776299 | PubTator, text mining | PubMed |
| Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. | Int J Mol Sci | 2023 | 36769018 | PubTator, text mining | PubMed |
| Derivation of Limbal Stem Cells from Human Adult Mesenchymal Stem Cells for the Treatment of Limbal Stem Cell Deficiency. | Int J Mol Sci | 2023 | 36768672 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells and Their Exocytotic Vesicles. | Int J Mol Sci | 2023 | 36768406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1052/papers?page=20